Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approvals
Pharma
Novo Nordisk, AstraZeneca, Ono—Fierce Pharma Asia
Novo Nordisk accuses KBP of fraudulent dealmaking. AZ buys FibroGen's China unit. Ono's newly acquired Deciphera won an FDA approval. And more.
Angus Liu
Feb 21, 2025 8:45am
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
Feb 14, 2025 6:24pm
Pfizer's blockbuster ADC Adcetris nabs FDA nod in LBCL
Feb 12, 2025 3:06pm
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
Jan 17, 2025 9:14pm
Breaking down the 55 new drug approvals of 2024
Jan 10, 2025 9:00am
FDA looks to clarify follow-up testing mandate for speedy nods
Jan 6, 2025 3:36pm
